Abstract
Germline mutations in DNA mismatch repair (DNA-MMR) genes, mainly MLH1, MSH2, and MSH6, underlie Hereditary non-polyposis colorectal cancer (HNPCC) and are mostly family-specific, with few reported founder mutations in MSH2 (Ashkenazim) MLH1 (Finnish). No mutations in colon cancer susceptibility genes have ever been reported in Druze individuals, a Moslem related faith encompassing ∼1,000,000 individuals worldwide. A novel MSH2 mutation is described in a Druze HNPCC family: a multigenerational family with 10 members in 4 generations affected with colorectal cancer (mean age of diagnosis 46.5 years), two with gastric cancer and one—endometrial cancer. Mutational analysis of the MSH2 gene using denaturing gradient gel electrophoresis (DGGE) and direct sequencing revealed the c.702delA mutation in codon 234 of exon 4 of the MSH2 gene leading to a premature early stop in codon 245, p.Thr234fsX245. Analysis of mutation-carrying or presumed carriers individuals’ offspring, revealed 11/42 asymptomatic mutation carriers, age range 17–50 years. The mutation was not present in two additional Druze HNPCC families and 20 Druze sporadic colon cancer patients. This is the first mutation ever reported in a colon cancer susceptibility gene in a Druze family and it appears not to be a founder mutation in Druze individuals with HNPCC.
Similar content being viewed by others
References
Berends MJ, Wu Y, Sijmons RH et al (2002) Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26–37
Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (lynch syndrome) an updated review. Cancer 78:1149–1167
Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of HNPCC and the feasibility of molecular screening for the disease. N Engl J Med 338:1481–1487
Vasen HF, Mecklin JP, Meera-Khan P et al (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425
Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for HNPCC proposed by the ICG on HNPCC. Gastroenterology 116:1453–1456
Peltomaki P, Vasen HF (1997) Mutations predisposing to HNPCC: database and results of a collaborative study. The international collaborative group on HNPCC. Gastroenterology 113:1146–1158
Nicolaides NC, Papadopoulos N, Liu B et al (1994) Mutations of two PMS homologues in hereditary non polyposis colorectal cancer. Nature 371:75–80
Akiyama Y, Sato H, Yamada T et al (1997) Germline mutation of the MSH6/GTBP gene in an atypical hereditary non-polyposis colorectal cancer kindred. Cancer Res 57:3920–3923
Miyaki M, Konishi M, Tanaka K et al (1997) Germline mutation of MSH6 as the cause of hereditary non polyposis colorectal cancer. Nat Genet 17:271–272
Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068–5074
Wijnen J, de Leeuw W, Vasen H et al (1993) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142–144
Wu Y, Berends MJ, Mensink RG et al (1999) Association of hereditary non polyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291–1298
Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary non polyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletions of the MSH2 gene. Am J Hum Genet 72:1088–1100
Foulkes WD, Thiffault I, Gruber SB et al (2002). The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71:1395–1412
Guillem JG, Moore HG, Palmer C et al (2004) A636P testing in Ashkenazi Jews. Fam Cancer 3:223–227
Nystrom-Lahti M, Kristo P, Nicolaides NC et al (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1:1203–1206
Moisio AL, Sistonen P, Weissenbach J et al (1996) Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet 59:1243–1251
Lynch HT, Coronel SM, Okimoto R et al (2004) A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291:718–724
Vardi-Saliternik R, Friedlander Y, Cohen T (2002) Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol 29:422–431
Gross DJ, Avishai N, Meiner V et al (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endocrinol Metab 81:147–149
Wu Y, Nystrom-Lahti M, Osinga J et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18:269–278
Gille JJ, Hogervost FB, Pals G, et al (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892–897
Syngal S, Fox EA, Li C et al (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 282:247–253
Kouraklis G, Misiakos EP (2005) Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 50:336–344
Ponz de Leon M, Benatti P, Di Gregorio C et al (2004) Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 90:882–887
Wagner A, van Kessel I, Kriege MG et al (2005) Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 4:295–300
Halbert CH, Lynch H, Lynch J et al (2004) Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164:1881–1887
Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16:201–213
Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4:245–248
Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994–2998
Lucci-Cordisco E, Zito I, Gensini F et al (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122:325–334
Fares F, Axelord Ran S, David M et al (2004) Identification of two mutations for ataxia telangiectasia among the Druze community. Prenat Diagn 24:358–362
Acknowledgements
This work was in part sponsored by a grant from the Israel cancer association (ICA) to E.F.; This work was done in part as fulfillment for the studies for a graduate degree from the University of Groningen, The Netherlands by Renée C. Niessen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zidan, J., Niessen, R.C., Laitman, Y. et al. A novel MSH2 germline mutation in a Druze HNPCC family. Familial Cancer 7, 135–139 (2008). https://doi.org/10.1007/s10689-007-9157-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-007-9157-5